INS and type 2 diabetes mellitus: Basal bolus insulin was used more in patients hospitalized in 2014–2019, probably because of the new guidelines for DFU treatment and in general because of the new guidelines for management of type 2 diabetes, as confirmed by the fact that in the 2008–2013 period oral hypoglycemic agents were significantly more used.